Pfizer Whistleblower Challenges Claim Dismissal

Law360, New York (March 21, 2007, 12:00 AM EDT) -- A former marketing vice president at Pfizer Inc. is appealing the dismissal of his whistleblower lawsuit accusing the pharmaceutical giant of illegally marketing a successful biotechnology drug, human growth hormone Genotropin.

The appeal, filed by Dr. Peter Rost in the U.S. Court of Appeals for the First Circuit on March 15, challenges the decision of the U.S. District Court for the District of Massachusetts to toss the action last September for lack of jurisdiction.

Rost was in charge of worldwide marketing for Genotropin, a recombinant, or...
To view the full article, register now.